7 completed, 1 unknown. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Completed 7, Unknown 1 |
Follow LG Life Sciences: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Compare and Evaluate the Efficacy and Safety of Ganilever PFS(Prefilled Syringe) and Orgalutran® Ganirelix acetate - Controlled Ovarian Stimulation | Phase 4 | Completed | LG Life Sciences | 255 | 2016-10-01 | 2019-07-02 |
| Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj. Somatropin - Short Stature, Idiopathic, Infant, Small for Gestational Age | Phase 4 | Completed | LG Life Sciences | 116 | 2016-08-11 | 2019-01-03 |
| Multicenter, Randomized, Open Label, Parallel Study to Evaluate the Efficacy & Safety of IVF-M HP Inj. vs. Menopur® Inj. IVF-M HP Inj., Menopur® Inj. - Infertility, Female | Phase 4 | Completed | LG Life Sciences | 112 | 2013-07-01 | 2016-02-03 |
| Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study) Gemigliptin + Metformin / Sitagliptin + Metformin / Glimepiride + Metformin - Type 2 Diabetes Mellitus | Phase 4 | Completed | LG Life Sciences | 69 | 2013-05-01 | 2015-03-13 |
| Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in CINV (Chemotherapy-induced Nausea and Vomiting) Associated With the Administration of MEC (Moderately Emetogenic Chemotherapy) Sancuso patch, Kytril inj.+Kytril tab. - Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV) | Phase 4 | Unknown | LG Life Sciences | 276 | 2012-02-01 | 2012-08-17 |
| Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in Chemotherapy-induced Nausea and Vomiting Associated With the Administration of Highly Emetogenic Chemotherapy (HEC) Sancuso patch, Zofran inj.+Zofran tab. - Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV) | Phase 4 | Completed | LG Life Sciences | 389 | 2011-08-01 | 2013-07-25 |
| Comparison of Efficacy and Safety Between Imidafenacin and Fesoterodine in Patients With Overactive Bladder Imidafenacin, Fesoterodine - Overactive Bladder | Phase 4 | Completed | LG Life Sciences | 207 | 2010-12-01 | 2012-04-16 |
| Safety and Efficacy of SR-hGH (Sustained-release Human Growth Hormone, Declage Inj.) sustained-release recombinant human GH (SR-rhGH) - Growth Hormone Deficiency | Phase 4 | Completed | LG Life Sciences | 132 | 2009-12-01 | 2012-10-05 |
Dwarfism, Pituitary (2) · Vomiting (2) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Dwarfism (1) · Infertility, Female (1) · Kidney Failure, Chronic (1) · Turner Syndrome (1) · Urinary Bladder, Overactive (1)
Human Growth Hormone (1) · LC15-0444 (1) · Metformin (1) · Sitagliptin Phosphate (1) · fesoterodine (1) · ganirelix (1) · glimepiride (1) · imidafenacin (1)
South Korea (6)
BW Lee (1) · Der-Sheng Sun, MD,PhD (1) · Dong Bok Shin, MD, PhD (1) · Hoon-Kyo Kim, MD,PhD (1) · In-Sook Woo, MD,PhD (1) · JH Jo (1) · JH Jung (1) · JH Kim (1) · Jin Seok Ahn, MD, PhD (1) · Jin-Hyoung Kang, MD,PhD (1) · Jong-Youl Jin, MD,PhD (1) · SE Park (1) · Suk-Young Park, MD,PhD (1) · Tae Won Kim, MD, PhD (1)